These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 15937338)
1. A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1. Rodriguez-Antona C; Axelson M; Otter C; Rane A; Ingelman-Sundberg M J Biol Chem; 2005 Aug; 280(31):28324-31. PubMed ID: 15937338 [TBL] [Abstract][Full Text] [Related]
2. Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers. Rodríguez-Antona C; Jande M; Rane A; Ingelman-Sundberg M Clin Pharmacol Ther; 2005 Apr; 77(4):259-70. PubMed ID: 15903124 [TBL] [Abstract][Full Text] [Related]
3. Genetic contribution to variable human CYP3A-mediated metabolism. Lamba JK; Lin YS; Schuetz EG; Thummel KE Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645 [TBL] [Abstract][Full Text] [Related]
4. The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. Finta C; Zaphiropoulos PG Gene; 2000 Dec; 260(1-2):13-23. PubMed ID: 11137287 [TBL] [Abstract][Full Text] [Related]
5. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. Schuetz JD; Kauma S; Guzelian PS J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982 [TBL] [Abstract][Full Text] [Related]
8. Genotype relationships in the CYP3A locus in Caucasians. Dally H; Bartsch H; Jäger B; Edler L; Schmezer P; Spiegelhalder B; Dienemann H; Drings P; Kayser K; Schulz V; Risch A Cancer Lett; 2004 Apr; 207(1):95-9. PubMed ID: 15050738 [TBL] [Abstract][Full Text] [Related]
9. Variability of CYP3A7 expression in human fetal liver. Leeder JS; Gaedigk R; Marcucci KA; Gaedigk A; Vyhlidal CA; Schindel BP; Pearce RE J Pharmacol Exp Ther; 2005 Aug; 314(2):626-35. PubMed ID: 15845858 [TBL] [Abstract][Full Text] [Related]
10. Helices F-G are important for the substrate specificities of CYP3A7. Torimoto N; Ishii I; Toyama K; Hata M; Tanaka K; Shimomura H; Nakamura H; Ariyoshi N; Ohmori S; Kitada M Drug Metab Dispos; 2007 Mar; 35(3):484-92. PubMed ID: 17178770 [TBL] [Abstract][Full Text] [Related]
11. Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population. Lee SS; Jung HJ; Park JS; Cha IJ; Cho DY; Shin JG Mol Biol Rep; 2010 Jan; 37(1):213-7. PubMed ID: 19585271 [TBL] [Abstract][Full Text] [Related]
12. CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele. Sim SC; Edwards RJ; Boobis AR; Ingelman-Sundberg M Pharmacogenet Genomics; 2005 Sep; 15(9):625-31. PubMed ID: 16041241 [TBL] [Abstract][Full Text] [Related]
13. Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers. Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Saito T; Parkinson A; Nakagawa K; Kamataki T Xenobiotica; 2005 Jan; 35(1):69-83. PubMed ID: 15788369 [TBL] [Abstract][Full Text] [Related]
14. Developmental expression of the major human hepatic CYP3A enzymes. Stevens JC; Hines RN; Gu C; Koukouritaki SB; Manro JR; Tandler PJ; Zaya MJ J Pharmacol Exp Ther; 2003 Nov; 307(2):573-82. PubMed ID: 12975492 [TBL] [Abstract][Full Text] [Related]
15. Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of cytochrome P450. Inoue E; Takahashi Y; Imai Y; Kamataki T Biochem Biophys Res Commun; 2000 Mar; 269(2):623-7. PubMed ID: 10708604 [TBL] [Abstract][Full Text] [Related]
16. Effects of cytochrome b(5) on drug oxidation activities of human cytochrome P450 (CYP) 3As: similarity of CYP3A5 with CYP3A4 but not CYP3A7. Yamaori S; Yamazaki H; Suzuki A; Yamada A; Tani H; Kamidate T; Fujita Ki; Kamataki T Biochem Pharmacol; 2003 Dec; 66(12):2333-40. PubMed ID: 14637191 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. Burk O; Tegude H; Koch I; Hustert E; Wolbold R; Glaeser H; Klein K; Fromm MF; Nuessler AK; Neuhaus P; Zanger UM; Eichelbaum M; Wojnowski L J Biol Chem; 2002 Jul; 277(27):24280-8. PubMed ID: 11940601 [TBL] [Abstract][Full Text] [Related]
18. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Schuetz JD; Beach DL; Guzelian PS Pharmacogenetics; 1994 Feb; 4(1):11-20. PubMed ID: 8004129 [TBL] [Abstract][Full Text] [Related]
19. Loss of CYP3A7 gene induction by 1,25-dihydroxyvitamin D3 is caused by less binding of VDR to the proximal ER6 in CYP3A7 gene. Hara H; Yasunami Y; Adachi T Biochem Biophys Res Commun; 2004 Sep; 321(4):909-15. PubMed ID: 15358113 [TBL] [Abstract][Full Text] [Related]
20. Whole-cell biotransformation assay for investigation of the human drug metabolizing enzyme CYP3A7. Neunzig I; Drăgan CA; Widjaja M; Schwaninger AE; Peters FT; Maurer HH; Bureik M Biochim Biophys Acta; 2011 Jan; 1814(1):161-7. PubMed ID: 20637317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]